Our company, a subsidiary of Korea University Medical Technology Holdings, is dedicated to developing next-generation healthcare solutions based on cutting-edge microbiome research. We have established unique technologies to regulate the tumor microenvironment, enabling the development of pharmaceuticals that can be combined with radiotherapy and immunotherapy. In addition, we provide consumer-centered healthcare solutions through functional foods that enhance immune balance, anti-aging, and life care, as well as cosmetics for skin health care, including atopic dermatitis and anti-aging. With a diversified pipeline spanning pharmaceuticals, healthcare foods, and cosmetics, we aim for global market expansion under the vision of “Global Partnership, Diversified Pipeline, and Next-Gen Leader.”

We provide microbiome-based anti-cancer adjuvants, probiotic health supplements, and diverse cosmetics such as sun cream, skin care, lotion, cream, and soap for personalized healthcare solutions.